Frederick National Laboratory for Cancer Research: VRC01 HIV Antibody Falls Short in Trials, But Don't Discount Antibodies Yet
May 21, 2021
May 21, 2021
FREDERICK, Maryland, May 21 (TNSJou) -- The National Institutes of Health's Frederick National Laboratory for Cancer Research issued the following news:
An anti-HIV antibody called VRC01 does not protect people from acquiring HIV, according to findings from the Antibody-Mediated Prevention (AMP) Trials.
The results were recently reported in the New England Journal of Medicine. While they indicate that this antibody alone is not a strong HIV-prevention measure, the . . .
An anti-HIV antibody called VRC01 does not protect people from acquiring HIV, according to findings from the Antibody-Mediated Prevention (AMP) Trials.
The results were recently reported in the New England Journal of Medicine. While they indicate that this antibody alone is not a strong HIV-prevention measure, the . . .